{"groups":[{"description":"Subjects enrolled in this cohort will receive 1 five day cycle of Artesunate suppositories prior to therapeutic resection of their lesion (if clinically indicated).\n\nArtesunate Suppositories","id":"FG000","title":"50 mg Artesunate Suppositories, 1 Cycle"},{"description":"Subjects enrolled in this cohort will receive 1 five day cycle of Artesunate suppositories prior to therapeutic resection of their lesion (if clinically indicated).\n\nArtesunate Suppositories","id":"FG001","title":"200 mg Artesunate Suppositories, 1 Cycle"},{"description":"Subjects enrolled in this cohort will receive 2 five day cycles of Artesunate suppositories prior to therapeutic resection of their lesion (if clinically indicated).\n\nArtesunate Suppositories","id":"FG002","title":"200 mg Artesunate Suppositories,2 Cycles"},{"description":"Subjects enrolled in this cohort will receive 3 five day cycles of Artesunate suppositories prior to therapeutic resection of their lesion (if clinically indicated).\n\nArtesunate Suppositories","id":"FG003","title":"200 mg Artesunate Suppositories,3 Cycles"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"9"},{"groupId":"FG002","numSubjects":"10"},{"groupId":"FG003","numSubjects":"8"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"9"},{"groupId":"FG002","numSubjects":"9"},{"groupId":"FG003","numSubjects":"8"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"1"},{"groupId":"FG003","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}